Amide Compound Inhibits PPAR-γ to Reduce Sebum Hypersecretion

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current treatments for skin disorders related to sebum overproduction, such as acne and seborrheic dermatitis, primarily focus on symptom relief rather than fundamental inhibition of sebum overproduction, leading to inadequate skin barrier function and potential bacterial overgrowth.

Innovation Solution

A cosmetic composition containing a specific amide compound that decreases the activity of peroxisome proliferator activated receptor gamma (PPAR-γ), inhibiting sebum hypersecretion by formulating into various cosmetic forms without cytotoxicity or skin side effects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If drug components such as antifungal agents, steroids, or other medications are used to treat skin disorders like acne and seborrheic dermatitis, then symptoms are relieved, but sebum overproduction is not fundamentally inhibited and skin barrier function deteriorates

Engineering Contradiction:

Improvesymptom relief effectivenessVSAvoidsebum overproduction and skin barrier deterioration

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent extracts and targets the specific molecular mechanism (PPAR-γ pathway) responsible for sebum overproduction. By using PPAR-γ inhibitors that selectively block this pathway, the treatment addresses the root cause rather than just symptoms, separating the fundamental inhibition function from symptomatic relief

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the therapeutic parameter from symptomatic management to molecular pathway inhibition. By targeting PPAR-γ activity and IGF-1 signaling, the treatment modifies the underlying biochemical parameters that control sebum production, achieving fundamental inhibition rather than temporary symptom relief

Inventive Principle:

Principle #35Parameter changes

2Ease of operation

If conventional treatments focus on symptom relief rather than fundamental inhibition of sebum overproduction, then immediate symptom improvement is achieved, but skin barrier function deteriorates and bacterial overgrowth occurs

Engineering Contradiction:

Improvesymptom relief speedVSAvoidskin barrier function and bacterial overgrowth

Core Design Contradiction:

Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary action by inhibiting PPAR-γ and IGF-1 pathways before sebum overproduction can cause skin barrier deterioration and bacterial overgrowth. This preventive approach addresses the root cause early, preventing the cascade of harmful effects rather than reacting to symptoms after they occur

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent implements preliminary anti-action by using PPAR-γ inhibitors to counteract the sebum production pathway before it leads to harmful outcomes. The treatment proactively blocks the molecular mechanism that would otherwise cause skin barrier deterioration and bacterial proliferation

Inventive Principle:

Principle #9Preliminary anti-action

Data Source

PatentUS11471391B2Cosmetic composition for inhibiting sebum hypersecretion

Publication Date: 2022.10.18 NEOPHARM CO LTD

AI summary

Provided are a cosmetic composition for inhibiting sebum hypersecretion and a method of inhibiting sebum hypersecretion using the same. According to the present invention, there may be provided the cosmetic composition of inhibiting and adjusting sebum secretion which is harmless to the human body with excellent skin safety and decreases activity of peroxisome proliferator activated receptor gamma (PPAR-γ) to fundamentally decrease sebum overproduction, thereby providing the skin with an effective effect, and a method of using the same.